nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenoxicam—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.27	0.406	CbGbCtD
Tenoxicam—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.144	0.215	CbGbCtD
Tenoxicam—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.144	0.215	CbGbCtD
Tenoxicam—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.109	0.163	CbGbCtD
Tenoxicam—PTGS1—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00308	0.0656	CbGpPWpGaD
Tenoxicam—PTGS2—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00245	0.0521	CbGpPWpGaD
Tenoxicam—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00185	0.00647	CcSEcCtD
Tenoxicam—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00183	0.00641	CcSEcCtD
Tenoxicam—Stomatitis—Tiotropium—chronic obstructive pulmonary disease	0.00181	0.00634	CcSEcCtD
Tenoxicam—Gastritis—Arformoterol—chronic obstructive pulmonary disease	0.00172	0.00603	CcSEcCtD
Tenoxicam—Gastritis—Formoterol—chronic obstructive pulmonary disease	0.00172	0.00603	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00172	0.00601	CcSEcCtD
Tenoxicam—Asthma—Formoterol—chronic obstructive pulmonary disease	0.00168	0.00589	CcSEcCtD
Tenoxicam—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.00168	0.00589	CcSEcCtD
Tenoxicam—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00166	0.0058	CcSEcCtD
Tenoxicam—Asthma—Montelukast—chronic obstructive pulmonary disease	0.00165	0.00576	CcSEcCtD
Tenoxicam—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.00165	0.00576	CcSEcCtD
Tenoxicam—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00164	0.00573	CcSEcCtD
Tenoxicam—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.00164	0.00572	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00163	0.00569	CcSEcCtD
Tenoxicam—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00163	0.00569	CcSEcCtD
Tenoxicam—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00161	0.00564	CcSEcCtD
Tenoxicam—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00161	0.00563	CcSEcCtD
Tenoxicam—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.00159	0.00556	CcSEcCtD
Tenoxicam—Peptic ulcer—Prednisone—chronic obstructive pulmonary disease	0.00158	0.00552	CcSEcCtD
Tenoxicam—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.00156	0.00546	CcSEcCtD
Tenoxicam—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00152	0.0053	CcSEcCtD
Tenoxicam—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00151	0.00527	CcSEcCtD
Tenoxicam—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.0015	0.00524	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.00148	0.00517	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.00148	0.00517	CcSEcCtD
Tenoxicam—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.00147	0.00514	CcSEcCtD
Tenoxicam—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.00147	0.00514	CcSEcCtD
Tenoxicam—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00147	0.0313	CbGpPWpGaD
Tenoxicam—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.00146	0.00511	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00146	0.0051	CcSEcCtD
Tenoxicam—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00145	0.00508	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.00139	0.00486	CcSEcCtD
Tenoxicam—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00139	0.00486	CcSEcCtD
Tenoxicam—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00483	CcSEcCtD
Tenoxicam—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00136	0.00476	CcSEcCtD
Tenoxicam—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00136	0.029	CbGpPWpGaD
Tenoxicam—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00135	0.00473	CcSEcCtD
Tenoxicam—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00134	0.0284	CbGpPWpGaD
Tenoxicam—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.00133	0.00465	CcSEcCtD
Tenoxicam—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.00133	0.00465	CcSEcCtD
Tenoxicam—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.00464	CcSEcCtD
Tenoxicam—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00462	CcSEcCtD
Tenoxicam—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00462	CcSEcCtD
Tenoxicam—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00461	CcSEcCtD
Tenoxicam—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.0013	0.00456	CcSEcCtD
Tenoxicam—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.0013	0.00454	CcSEcCtD
Tenoxicam—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.00454	CcSEcCtD
Tenoxicam—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00452	CcSEcCtD
Tenoxicam—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00129	0.00451	CcSEcCtD
Tenoxicam—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00128	0.00449	CcSEcCtD
Tenoxicam—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.0044	CcSEcCtD
Tenoxicam—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00439	CcSEcCtD
Tenoxicam—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00437	CcSEcCtD
Tenoxicam—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00437	CcSEcCtD
Tenoxicam—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00436	CcSEcCtD
Tenoxicam—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.00436	CcSEcCtD
Tenoxicam—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00436	CcSEcCtD
Tenoxicam—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00123	0.00431	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.0043	CcSEcCtD
Tenoxicam—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00428	CcSEcCtD
Tenoxicam—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00426	CcSEcCtD
Tenoxicam—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00426	CcSEcCtD
Tenoxicam—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00121	0.00423	CcSEcCtD
Tenoxicam—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.0012	0.00419	CcSEcCtD
Tenoxicam—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.00419	CcSEcCtD
Tenoxicam—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00417	CcSEcCtD
Tenoxicam—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00119	0.00416	CcSEcCtD
Tenoxicam—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00119	0.00415	CcSEcCtD
Tenoxicam—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00119	0.00415	CcSEcCtD
Tenoxicam—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.00413	CcSEcCtD
Tenoxicam—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00413	CcSEcCtD
Tenoxicam—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.00413	CcSEcCtD
Tenoxicam—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00118	0.00413	CcSEcCtD
Tenoxicam—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00117	0.0041	CcSEcCtD
Tenoxicam—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.0041	CcSEcCtD
Tenoxicam—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00116	0.00407	CcSEcCtD
Tenoxicam—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00116	0.00404	CcSEcCtD
Tenoxicam—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00404	CcSEcCtD
Tenoxicam—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00403	CcSEcCtD
Tenoxicam—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00402	CcSEcCtD
Tenoxicam—PTGS1—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.00115	0.0245	CbGpPWpGaD
Tenoxicam—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00112	0.00392	CcSEcCtD
Tenoxicam—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.0039	CcSEcCtD
Tenoxicam—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00389	CcSEcCtD
Tenoxicam—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00387	CcSEcCtD
Tenoxicam—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.00387	CcSEcCtD
Tenoxicam—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00382	CcSEcCtD
Tenoxicam—PTGS2—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.00107	0.0229	CbGpPWpGaD
Tenoxicam—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00375	CcSEcCtD
Tenoxicam—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00375	CcSEcCtD
Tenoxicam—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00107	0.0227	CbGpPWpGaD
Tenoxicam—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00367	CcSEcCtD
Tenoxicam—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00104	0.00365	CcSEcCtD
Tenoxicam—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00362	CcSEcCtD
Tenoxicam—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00362	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00102	0.00358	CcSEcCtD
Tenoxicam—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00355	CcSEcCtD
Tenoxicam—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00101	0.00355	CcSEcCtD
Tenoxicam—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00354	CcSEcCtD
Tenoxicam—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000999	0.00349	CcSEcCtD
Tenoxicam—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000995	0.00348	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000992	0.00347	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000992	0.00347	CcSEcCtD
Tenoxicam—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000979	0.00342	CcSEcCtD
Tenoxicam—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000977	0.00341	CcSEcCtD
Tenoxicam—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000977	0.00341	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000972	0.0034	CcSEcCtD
Tenoxicam—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00097	0.0207	CbGpPWpGaD
Tenoxicam—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000957	0.00335	CcSEcCtD
Tenoxicam—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000957	0.00335	CcSEcCtD
Tenoxicam—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000957	0.00335	CcSEcCtD
Tenoxicam—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000957	0.00335	CcSEcCtD
Tenoxicam—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000942	0.00329	CcSEcCtD
Tenoxicam—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000939	0.00328	CcSEcCtD
Tenoxicam—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000939	0.00328	CcSEcCtD
Tenoxicam—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000938	0.00328	CcSEcCtD
Tenoxicam—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000938	0.00328	CcSEcCtD
Tenoxicam—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00093	0.00325	CcSEcCtD
Tenoxicam—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00093	0.00325	CcSEcCtD
Tenoxicam—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000927	0.00324	CcSEcCtD
Tenoxicam—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000922	0.00322	CcSEcCtD
Tenoxicam—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00092	0.00321	CcSEcCtD
Tenoxicam—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000918	0.00321	CcSEcCtD
Tenoxicam—PTGS2—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.000912	0.0194	CbGpPWpGaD
Tenoxicam—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000911	0.00318	CcSEcCtD
Tenoxicam—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000904	0.00316	CcSEcCtD
Tenoxicam—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000904	0.00316	CcSEcCtD
Tenoxicam—PTGS1—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.0009	0.0192	CbGpPWpGaD
Tenoxicam—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00089	0.00311	CcSEcCtD
Tenoxicam—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000887	0.0031	CcSEcCtD
Tenoxicam—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000878	0.00307	CcSEcCtD
Tenoxicam—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000874	0.00306	CcSEcCtD
Tenoxicam—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000862	0.00301	CcSEcCtD
Tenoxicam—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000861	0.00301	CcSEcCtD
Tenoxicam—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000854	0.00298	CcSEcCtD
Tenoxicam—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000854	0.00298	CcSEcCtD
Tenoxicam—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000843	0.00295	CcSEcCtD
Tenoxicam—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000843	0.00295	CcSEcCtD
Tenoxicam—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000839	0.00293	CcSEcCtD
Tenoxicam—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000832	0.00291	CcSEcCtD
Tenoxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	0.000829	0.0177	CbGpPWpGaD
Tenoxicam—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000827	0.00289	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000827	0.00289	CcSEcCtD
Tenoxicam—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000826	0.00289	CcSEcCtD
Tenoxicam—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000825	0.00289	CcSEcCtD
Tenoxicam—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000825	0.00289	CcSEcCtD
Tenoxicam—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000819	0.00286	CcSEcCtD
Tenoxicam—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000819	0.00286	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00081	0.00283	CcSEcCtD
Tenoxicam—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000809	0.00283	CcSEcCtD
Tenoxicam—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000806	0.00282	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000801	0.0028	CcSEcCtD
Tenoxicam—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.0008	0.0028	CcSEcCtD
Tenoxicam—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000797	0.00279	CcSEcCtD
Tenoxicam—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000796	0.00278	CcSEcCtD
Tenoxicam—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000793	0.00277	CcSEcCtD
Tenoxicam—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000792	0.00277	CcSEcCtD
Tenoxicam—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000788	0.00275	CcSEcCtD
Tenoxicam—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000786	0.00275	CcSEcCtD
Tenoxicam—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000786	0.00275	CcSEcCtD
Tenoxicam—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000785	0.00274	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000781	0.00273	CcSEcCtD
Tenoxicam—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000779	0.00272	CcSEcCtD
Tenoxicam—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000773	0.0027	CcSEcCtD
Tenoxicam—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000767	0.00268	CcSEcCtD
Tenoxicam—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000761	0.00266	CcSEcCtD
Tenoxicam—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000761	0.00266	CcSEcCtD
Tenoxicam—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000754	0.00264	CcSEcCtD
Tenoxicam—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.000752	0.016	CbGpPWpGaD
Tenoxicam—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000748	0.00261	CcSEcCtD
Tenoxicam—PTGS1—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000748	0.0159	CbGpPWpGaD
Tenoxicam—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000747	0.00261	CcSEcCtD
Tenoxicam—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000747	0.00261	CcSEcCtD
Tenoxicam—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000745	0.0026	CcSEcCtD
Tenoxicam—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000743	0.0026	CcSEcCtD
Tenoxicam—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000718	0.00251	CcSEcCtD
Tenoxicam—PTGS2—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.000715	0.0152	CbGpPWpGaD
Tenoxicam—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000705	0.00247	CcSEcCtD
Tenoxicam—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000705	0.00247	CcSEcCtD
Tenoxicam—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000705	0.015	CbGpPWpGaD
Tenoxicam—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000705	0.00246	CcSEcCtD
Tenoxicam—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000703	0.00246	CcSEcCtD
Tenoxicam—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000691	0.00242	CcSEcCtD
Tenoxicam—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000687	0.0024	CcSEcCtD
Tenoxicam—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000687	0.0024	CcSEcCtD
Tenoxicam—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000678	0.0144	CbGpPWpGaD
Tenoxicam—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000677	0.00237	CcSEcCtD
Tenoxicam—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000677	0.00237	CcSEcCtD
Tenoxicam—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000673	0.00235	CcSEcCtD
Tenoxicam—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000666	0.00233	CcSEcCtD
Tenoxicam—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000663	0.00232	CcSEcCtD
Tenoxicam—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000655	0.00229	CcSEcCtD
Tenoxicam—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000655	0.00229	CcSEcCtD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.00065	0.0138	CbGpPWpGaD
Tenoxicam—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000649	0.00227	CcSEcCtD
Tenoxicam—PTGS1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000644	0.0137	CbGpPWpGaD
Tenoxicam—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000642	0.00224	CcSEcCtD
Tenoxicam—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00064	0.00224	CcSEcCtD
Tenoxicam—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000635	0.00222	CcSEcCtD
Tenoxicam—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000633	0.00221	CcSEcCtD
Tenoxicam—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000633	0.00221	CcSEcCtD
Tenoxicam—Piroxicam—ALB—chronic obstructive pulmonary disease	0.000632	1	CrCbGaD
Tenoxicam—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00062	0.00217	CcSEcCtD
Tenoxicam—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000619	0.00216	CcSEcCtD
Tenoxicam—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000609	0.00213	CcSEcCtD
Tenoxicam—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000609	0.00213	CcSEcCtD
Tenoxicam—Rash—Formoterol—chronic obstructive pulmonary disease	0.000604	0.00211	CcSEcCtD
Tenoxicam—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000604	0.00211	CcSEcCtD
Tenoxicam—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000603	0.00211	CcSEcCtD
Tenoxicam—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000603	0.00211	CcSEcCtD
Tenoxicam—Headache—Formoterol—chronic obstructive pulmonary disease	0.0006	0.0021	CcSEcCtD
Tenoxicam—Headache—Arformoterol—chronic obstructive pulmonary disease	0.0006	0.0021	CcSEcCtD
Tenoxicam—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000598	0.00209	CcSEcCtD
Tenoxicam—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.000597	0.0127	CbGpPWpGaD
Tenoxicam—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000596	0.00208	CcSEcCtD
Tenoxicam—PTGS2—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000594	0.0126	CbGpPWpGaD
Tenoxicam—Rash—Montelukast—chronic obstructive pulmonary disease	0.000591	0.00207	CcSEcCtD
Tenoxicam—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000591	0.00207	CcSEcCtD
Tenoxicam—Headache—Montelukast—chronic obstructive pulmonary disease	0.000588	0.00205	CcSEcCtD
Tenoxicam—PTGS1—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000585	0.0125	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—MMP12—chronic obstructive pulmonary disease	0.000583	0.0124	CbGpPWpGaD
Tenoxicam—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000582	0.00204	CcSEcCtD
Tenoxicam—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000581	0.00203	CcSEcCtD
Tenoxicam—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000579	0.00202	CcSEcCtD
Tenoxicam—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000575	0.00201	CcSEcCtD
Tenoxicam—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000571	0.002	CcSEcCtD
Tenoxicam—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00057	0.00199	CcSEcCtD
Tenoxicam—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000569	0.00199	CcSEcCtD
Tenoxicam—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000569	0.00199	CcSEcCtD
Tenoxicam—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000569	0.00199	CcSEcCtD
Tenoxicam—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000566	0.00198	CcSEcCtD
Tenoxicam—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000557	0.00195	CcSEcCtD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000547	0.0116	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000543	0.0116	CbGpPWpGaD
Tenoxicam—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000537	0.00188	CcSEcCtD
Tenoxicam—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000519	0.00181	CcSEcCtD
Tenoxicam—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000519	0.00181	CcSEcCtD
Tenoxicam—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000512	0.0109	CbGpPWpGaD
Tenoxicam—PTGS2—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000511	0.0109	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000502	0.0107	CbGpPWpGaD
Tenoxicam—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000496	0.00173	CcSEcCtD
Tenoxicam—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000493	0.0105	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000484	0.0103	CbGpPWpGaD
Tenoxicam—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000481	0.00168	CcSEcCtD
Tenoxicam—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000479	0.00167	CcSEcCtD
Tenoxicam—PTGS1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000468	0.00997	CbGpPWpGaD
Tenoxicam—PTGS2—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000465	0.0099	CbGpPWpGaD
Tenoxicam—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000465	0.00162	CcSEcCtD
Tenoxicam—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000462	0.00161	CcSEcCtD
Tenoxicam—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000462	0.00161	CcSEcCtD
Tenoxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000461	0.00982	CbGpPWpGaD
Tenoxicam—PTGS1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000451	0.00961	CbGpPWpGaD
Tenoxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.000433	0.00922	CbGpPWpGaD
Tenoxicam—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000427	0.00149	CcSEcCtD
Tenoxicam—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000422	0.00147	CcSEcCtD
Tenoxicam—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000415	0.00145	CcSEcCtD
Tenoxicam—PTGS2—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.000414	0.00881	CbGpPWpGaD
Tenoxicam—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000412	0.00144	CcSEcCtD
Tenoxicam—PTGS1—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000407	0.00868	CbGpPWpGaD
Tenoxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.0004	0.00851	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000399	0.00849	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000397	0.00846	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000396	0.00844	CbGpPWpGaD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00039	0.00136	CcSEcCtD
Tenoxicam—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000382	0.00134	CcSEcCtD
Tenoxicam—PTGS2—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.000377	0.00804	CbGpPWpGaD
Tenoxicam—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000377	0.00132	CcSEcCtD
Tenoxicam—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000377	0.00132	CcSEcCtD
Tenoxicam—PTGS2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000372	0.00791	CbGpPWpGaD
Tenoxicam—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00037	0.00129	CcSEcCtD
Tenoxicam—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000366	0.00128	CcSEcCtD
Tenoxicam—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000359	0.00126	CcSEcCtD
Tenoxicam—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000343	0.0012	CcSEcCtD
Tenoxicam—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000339	0.00721	CbGpPWpGaD
Tenoxicam—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000332	0.00116	CcSEcCtD
Tenoxicam—PTGS1—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000329	0.007	CbGpPWpGaD
Tenoxicam—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000328	0.00699	CbGpPWpGaD
Tenoxicam—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000328	0.00115	CcSEcCtD
Tenoxicam—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000327	0.00114	CcSEcCtD
Tenoxicam—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000327	0.00114	CcSEcCtD
Tenoxicam—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000325	0.00114	CcSEcCtD
Tenoxicam—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000325	0.00114	CcSEcCtD
Tenoxicam—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000323	0.00689	CbGpPWpGaD
Tenoxicam—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000322	0.00113	CcSEcCtD
Tenoxicam—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000308	0.00108	CcSEcCtD
Tenoxicam—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000299	0.00638	CbGpPWpGaD
Tenoxicam—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000299	0.00105	CcSEcCtD
Tenoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000293	0.00623	CbGpPWpGaD
Tenoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000289	0.00615	CbGpPWpGaD
Tenoxicam—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000288	0.00615	CbGpPWpGaD
Tenoxicam—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000285	0.00607	CbGpPWpGaD
Tenoxicam—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000278	0.00097	CcSEcCtD
Tenoxicam—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00027	0.000945	CcSEcCtD
Tenoxicam—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000267	0.000932	CcSEcCtD
Tenoxicam—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000264	0.00563	CbGpPWpGaD
Tenoxicam—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000261	0.00556	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000259	0.00551	CbGpPWpGaD
Tenoxicam—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000258	0.000901	CcSEcCtD
Tenoxicam—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000249	0.000871	CcSEcCtD
Tenoxicam—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000246	0.00524	CbGpPWpGaD
Tenoxicam—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00024	0.00511	CbGpPWpGaD
Tenoxicam—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00024	0.000837	CcSEcCtD
Tenoxicam—Rash—Prednisone—chronic obstructive pulmonary disease	0.000238	0.00083	CcSEcCtD
Tenoxicam—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000237	0.00083	CcSEcCtD
Tenoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000237	0.00505	CbGpPWpGaD
Tenoxicam—Headache—Prednisone—chronic obstructive pulmonary disease	0.000236	0.000825	CcSEcCtD
Tenoxicam—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000224	0.000782	CcSEcCtD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.000214	0.00456	CbGpPWpGaD
Tenoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000213	0.00453	CbGpPWpGaD
Tenoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00021	0.00447	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.00021	0.00447	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000203	0.00432	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000203	0.00432	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000202	0.00431	CbGpPWpGaD
Tenoxicam—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.0002	0.00426	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000186	0.00396	CbGpPWpGaD
Tenoxicam—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000184	0.00391	CbGpPWpGaD
Tenoxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000175	0.00373	CbGpPWpGaD
Tenoxicam—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000174	0.00371	CbGpPWpGaD
Tenoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000172	0.00367	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000167	0.00357	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000165	0.00351	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000162	0.00346	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000161	0.00343	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000161	0.00343	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000161	0.00342	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000159	0.0034	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.000159	0.00339	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000152	0.00323	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.000151	0.00322	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00015	0.00319	CbGpPWpGaD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	0.000149	0.00318	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	0.00014	0.00299	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000131	0.00279	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.00268	CbGpPWpGaD
Tenoxicam—SLC22A8—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000126	0.00268	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000124	0.00265	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.00012	0.00255	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000111	0.00237	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	0.000108	0.0023	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000107	0.00227	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000107	0.00227	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000105	0.00224	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000104	0.00221	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	0.000103	0.0022	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.99e-05	0.00213	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	9.75e-05	0.00208	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.66e-05	0.00206	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	9.65e-05	0.00205	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.53e-05	0.00203	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	9.49e-05	0.00202	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.28e-05	0.00198	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.21e-05	0.00196	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.16e-05	0.00195	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.03e-05	0.00192	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	9.03e-05	0.00192	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.4e-05	0.00179	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	8.04e-05	0.00171	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.93e-05	0.00169	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	7.88e-05	0.00168	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	7.66e-05	0.00163	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	7.51e-05	0.0016	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.37e-05	0.00157	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	7.37e-05	0.00157	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.31e-05	0.00156	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	7.17e-05	0.00153	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.69e-05	0.00142	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.66e-05	0.00142	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	6.62e-05	0.00141	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.4e-05	0.00136	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	6.06e-05	0.00129	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.96e-05	0.00127	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	5.47e-05	0.00116	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.36e-05	0.00114	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.31e-05	0.00113	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.25e-05	0.00112	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	5.11e-05	0.00109	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.93e-05	0.00105	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.88e-05	0.00104	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.88e-05	0.00104	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.84e-05	0.00103	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	4.75e-05	0.00101	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.55e-05	0.000969	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.5e-05	0.000959	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.45e-05	0.000948	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.41e-05	0.00094	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.1e-05	0.000873	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	3.93e-05	0.000837	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.92e-05	0.000834	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.87e-05	0.000825	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—KL—chronic obstructive pulmonary disease	3.65e-05	0.000778	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.61e-05	0.000769	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.53e-05	0.000753	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.52e-05	0.000749	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.42e-05	0.000728	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.37e-05	0.000718	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.25e-05	0.000693	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.14e-05	0.000669	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.98e-05	0.000635	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	2.74e-05	0.000583	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.71e-05	0.000578	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.68e-05	0.00057	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.59e-05	0.000552	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.56e-05	0.000546	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.49e-05	0.000531	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.39e-05	0.000509	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.36e-05	0.000504	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.34e-05	0.000498	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	2.28e-05	0.000486	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.16e-05	0.000459	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	2.03e-05	0.000431	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.94e-05	0.000413	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	1.92e-05	0.00041	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	1.84e-05	0.000391	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.8e-05	0.000383	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.77e-05	0.000378	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.65e-05	0.000352	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	1.61e-05	0.000342	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.57e-05	0.000334	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.54e-05	0.000328	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	1.21e-05	0.000259	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	1.19e-05	0.000254	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.06e-05	0.000227	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.02e-05	0.000217	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	9.15e-06	0.000195	CbGpPWpGaD
